公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of salesfrom global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
公司地址 The Heights, Building 5, First Floor, Weybridge, Surrey, GBR, KT13 0NY
電話號碼 +44 1932959500
傳真號碼 --
公司網頁 https://www.haleon.com
員工數量 24535
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Adrian Morris General Counsel -- 13/03/2026
Ms. Claire Dickson Chief Digital and Technology Officer -- 13/03/2026
Mr. Bjorn Timelin Head, Strategy -- 13/03/2026
Ms. Amanda Mellor Company Secretary -- 13/03/2026
Mr. Kedar Lele President, India Subcontinent -- 13/03/2026
Mr. Carl Haney Chief Research and Development Officer -- 13/03/2026
Ms. Dawn Allen Director and Chief Financial Officer 英鎊 749.00K 13/03/2026
Ms. Line De Decker Chief Human Resources Officer -- 13/03/2026
Ms. Nathalie Gerschtein Keraudy President, North America -- 13/03/2026
Ms. Namrata P Patel Chief Supply Chain Officer -- 13/03/2026
Mr. Ed Petter Chief Corporate Affairs Officer -- 13/03/2026
Mr. Brian James McNamara Chief Executive Officer and Director 英鎊 1.34M 13/03/2026
Mr. Keith Choy President, Asia Pacific -- 13/03/2026
Mr. Filippo Lanzi President, EMEA and LatAm -- 13/03/2026
 
董事會成員
董事會 職務 更新日期
Ms. Nancy Avila Independent Director 13/03/2026
Mr. Alan James Stewart Senior Independent Director 13/03/2026
Mr. Matthew J. Shattock Independent Director 13/03/2026
Ms. Dawn Allen Director and Chief Financial Officer 13/03/2026
Ms. Blathnaid Bergin Independent Director 13/03/2026
Mr. Manvinder Singh Banga Chairman of the Board 13/03/2026
Dr. Dame Vivienne Cox Independent Director 13/03/2026
Ms. Tracy Jayne Clarke Independent Director 13/03/2026
Mr. Brian James McNamara Chief Executive Officer and Director 13/03/2026
Ms. Marie Anne Aymerich Independent Director 13/03/2026
Ms. Asmita Dubey Independent Director 13/03/2026
 
所屬ETF (更新日期: 25/04/2026 02:09)
代號 名稱 佔比% 持有日期
PPHVanEck Pharmaceutical ETF0.09%31/03/2026
QLTIGMO International Quality ETF0.02%28/02/2026
AVDEAvantis International Equity ETF0.02%31/03/2026
AQECAQE Core ETF0.02%31/03/2026
RGEFRockefeller Global Equity ETF0.02%31/03/2026
GKATScharf Global Opportunity ETF0.01%31/10/2025
YLDEFranklin ClearBridge Enhanced Inc ETF0.01%11/03/2026
APIEActivePassive International Equity ETF0.005%31/03/2026
FFNDOne Global ETF0.002%31/03/2026
SPWOSP Funds S&P World ETF0.001%31/03/2026
AVSDAvantis Responsible International Eq ETF0.001%31/03/2026
DFAXDimensional World ex US Core Eq 2 ETF0.0003%31/03/2026
MEDXHorizon Kinetics Medical ETF0.0003%31/03/2026
BRESBurney U.S. Equity Select ETF0.0001%31/03/2026
AVOSAvos Global Equities ETF0.00003%31/03/2026
AAUAAlpha Architect US Equity 3 ETF0.00001%31/03/2026
AAUSAlpha Architect US Equity ETF<0.000001%08/08/2025
AVTMAvantis Total Equity Markets ETF<0.000001%14/03/2026
BLUXBluemonte Dynamic Total Market ETF<0.000001%10/02/2026
DAKDakota Active Equity ETF<0.000001%29/01/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.